Science Explorer Back to mapMap
Discussion
Researcher · University of Nairobi · Kenya

Brian Maina Ogoti

Brian Maina Ogoti publishes mostly in Endocrinology, Molecular Medicine and Critical Care and Intensive Care Medicine, on topics such as Escherichia coli research studies, Antibiotic Resistance in Bacteria and Nosocomial Infections in ICU.

ORCID 0000-0002-4992-6838 OpenAlex
World rank
#4,631,352
of 7,710,434 ranked researchers
Rank in Kenya
#4,301
of 7,520
Works
30
Citations
110
Citations per work
3.7
h-index
6
i10-index 6Top 86% in Endocrinology
Brian Maina Ogoti

What does Brian Maina Ogoti research?

Brian Maina Ogoti's work is mostly in Biochemistry, Genetics and Molecular Biology (29%), Medicine (20%), Immunology and Microbiology (10%).

Life Sciences: 13 works · 44.1% of their workBiochemistry, Genetics and Molecular Biology: 9 works · 28.6% of their workEndocrinology: 5 works · 16.7% of their workMolecular Medicine: 4 works · 11.9% of their workImmunology and Microbiology: 3 works · 9.5% of their workVirology: 3 works · 9.5% of their workAgricultural and Biological Sciences: 2 works · 6.0% of their workFood Science: 2 works · 6.0% of their workEverything else: 11 works · 35.7% of their workHealth Sciences: 6 works · 20.2% of their workMedicine: 6 works · 20.2% of their workCritical Care and Intensive Care Medicine: 3 works · 10.7% of their workInfectious Diseases: 3 works · 9.5% of their workTHEIR WORKBrian Maina Ogoti30works
Life Sciences44%Health Sciences20%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology928.6%
    2. Immunology and Microbiology39.5%
    3. Agricultural and Biological Sciences26.0%
  2. Everything else1135.7%
    1. Medicine620.2%
  1. 1Endocrinology17% of their works
  2. 2Molecular Medicine12% of their works
  3. 3Critical Care and Intensive Care Medicine11% of their works
  4. 4Infectious Diseases10% of their works
  5. 5Virology10% of their works
  6. 6Food Science6% of their works

Research topics

Which keywords describe Brian Maina Ogoti's research?

The keywords of their largest research topics: Epidemiology, Escherichia coli, Pathogenicity, Antibiotic Resistance, Multidrug-Resistant Bacteria, ICU, Ventilator-associated Pneumonia and Pathogenesis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Epidemiology113 topics
  2. Escherichia coli111 topic
  3. Pathogenicity111 topic
  4. Antibiotic Resistance101 topic
  5. Multidrug-Resistant Bacteria101 topic
  6. ICU91 topic
  7. Ventilator-associated Pneumonia91 topic
  8. Pathogenesis82 topics
  9. Coronavirus72 topics
  10. Vaccine72 topics
  11. Rabies61 topic
  12. Virus61 topic
  13. SARS-CoV-251 topic
  14. spike protein51 topic
  15. Camel Milk31 topic
  16. Cholera31 topic
  17. Nutritional31 topic
  18. Vibrio cholerae31 topic
  19. Circovirus21 topic
  20. Porcine Reproductive and Respiratory Syndrome Virus21 topic

Where does Brian Maina Ogoti work?

Brian Maina Ogoti's main affiliation in the publication record is University of Nairobi, Kenya.

How many publications and citations does Brian Maina Ogoti have?

OpenAlex counts 30 works and 110 citations for Brian Maina Ogoti, an h-index of 6, ranking #4,631,352 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Brian Maina Ogoti. Posts are plain text and can be reported.